Hepatitis E immunosuppressed patients and assisted pregnancy: Is it time to discuss neglected issues?
作者信息
Anyfantakis D, Symvoulakis E K, Kastanakis S
机构信息
Primary Health Care Centre of Kissamos, Chania, Crete, Greece.
Private Family Practice Unit, Heraklion, Crete, Greece.
出版信息
J Med Life. 2017 Apr-Jun;10(2):150.
Abstract
摘要
相似文献
1
Hepatitis E immunosuppressed patients and assisted pregnancy: Is it time to discuss neglected issues?
J Med Life. 2017 Apr-Jun;10(2):150.
2
Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.通过一种新型疫苗接种方法在免疫抑制的小鼠乙型肝炎病毒携带者中诱导和维持抗-HBs：对乙型肝炎病毒感染的肝移植受者的应用意义
J Gastroenterol. 2004 Sep;39(9):851-8. doi: 10.1007/s00535-004-1401-2.
3
Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.免疫抑制个体在高剂量短间隔接种乙型肝炎病毒疫苗后抗体应答率受损。
Hepatogastroenterology. 2003 Jan-Feb;50(49):217-21.
4
Hepatitis E: source and route of infection, clinical manifestations and new developments.戊型肝炎：感染源和途径、临床表现和新进展。
J Viral Hepat. 2013 Jan;20(1):1-11. doi: 10.1111/jvh.12024.
5
Hepatitis E, the neglected one.戊型肝炎，被忽视的肝炎。
Liver Int. 2016 Jan;36 Suppl 1:130-4. doi: 10.1111/liv.13014.
6
[Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients].[戊型肝炎：从人畜共患病传播到免疫抑制患者的慢性感染]
Med Sci (Paris). 2008 Dec;24(12):1023-5. doi: 10.1051/medsci/200824121023.
7
[Hepatitis B virus infection in pregnancy and the immunosuppressed patient].
Gastroenterol Hepatol. 2015 Jan;38(1):31-9. doi: 10.1016/j.gastrohep.2014.05.011. Epub 2014 Jul 25.
8
Immunopathogenesis of hepatitis E virus infection.戊型肝炎病毒感染的免疫发病机制。
Semin Liver Dis. 2013 Feb;33(1):71-8. doi: 10.1055/s-0033-1338118. Epub 2013 Apr 5.
9
Clinical presentation of hepatitis E.戊型肝炎的临床特征。
Virus Res. 2011 Oct;161(1):15-22. doi: 10.1016/j.virusres.2011.03.017. Epub 2011 Mar 31.
10
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.免疫抑制癌症患者的乙型肝炎：发病机制、发生率和预防。
Crit Rev Oncol Hematol. 2013 Jul;87(1):12-27. doi: 10.1016/j.critrevonc.2012.12.004. Epub 2013 Jan 11.
本文引用的文献
1
Development of new immunotherapy treatments in different cancer types.不同癌症类型新免疫疗法的研发。
J Med Life. 2016 Jul-Sep;9(3):240-248.
2
Prophylaxis against hepatitis E: at risk populations and human vaccines.戊型肝炎的预防：高危人群与人类疫苗
Expert Rev Vaccines. 2016 Jul;15(7):815-27. doi: 10.1586/14760584.2016.1143365. Epub 2016 Feb 5.
3
Long-term efficacy of a hepatitis E vaccine.戊型肝炎疫苗的长期疗效。
N Engl J Med. 2015 Mar 5;372(10):914-22. doi: 10.1056/NEJMoa1406011.
4
Making hepatitis E a vaccine-preventable disease.将戊型肝炎变为可通过疫苗预防的疾病。
N Engl J Med. 2015 Mar 5;372(10):899-901. doi: 10.1056/NEJMp1415240.
5
Hepatitis E screening for blood donations: an urgent need?献血中的戊型肝炎筛查：迫切需要吗？
Lancet. 2014 Nov 15;384(9956):1729-30. doi: 10.1016/S0140-6736(14)61187-9. Epub 2014 Jul 28.
6
Should we screen blood products for hepatitis E virus RNA ?我们应该对血液制品进行戊型肝炎病毒RNA筛查吗？
Lancet. 2014 Jan 18;383(9913):218. doi: 10.1016/S0140-6736(14)60072-6.
7
[Hepatitis E].[戊型肝炎]
Infez Med. 2013 Sep;21(3):175-88.
Zotero 插件